New 21-valent conjugate vaccine authorized to combat invasive pneumococcal disease and pneumonia in individuals aged 18 and older.
Heather Platt, MD
Advertisement
Clinical Research Director at Merck Research Laboratories.
Articles by Heather Platt, MD
Heather Platt, MD, discusses Merck’s ongoing research into real-world effectiveness and cost-effectiveness and offers a preview of data to be presented at ESCMID 2025.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of October 18-October 24
2
Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat
3
High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol
4
